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Abstract
Background: Defensins comprise a group of antimicrobial peptides, widely recognized as
important elements of the innate immune system in both animals and plants. Cationicity, rather
than the secondary structure, is believed to be the major factor defining the antimicrobial activity of
defensins. To test this hypothesis and to improve the activity of the newly identified avian
b-defensin Apl_AvBD2 by enhancing the cationicity, we performed in silico site directed
mutagenesis, keeping the predicted secondary structure intact. Molecular dynamics (MD)
simulation studies were done to predict the activity. Mutant proteins were made by in vitro site
directed mutagenesis and recombinant protein expression, and tested for antimicrobial activity to
confirm the results obtained in MD simulation analysis.
Results: MD simulation revealed subtle, but critical, structural variations between the wild type
Apl_AvBD2 and the more cationic in silico mutants, which were not detected in the initial structural
prediction by homology modelling. The C-terminal cationic ‘claw’ region, important in
antimicrobial activity, which was intact in the wild type, showed changes in shape and orientation
in all the mutant peptides. Mutant peptides also showed increased solvent accessible surface area
and more number of hydrogen bonds with the surrounding water molecules. In functional studies,
the Escherichia coli expressed, purified recombinant mutant proteins showed total loss of
antimicrobial activity compared to the wild type protein.
Conclusion: The study revealed that cationicity alone is not the determining factor in the
microbicidal activity of antimicrobial peptides. Factors affecting the molecular dynamics such as
hydrophobicity, electrostatic interactions and the potential for oligomerization may also play
fundamental roles. It points to the usefulness of MD simulation studies in successful engineering of
antimicrobial peptides for improved activity and other desirable functions.
Page 1 of 9




Defensins are recognized as important elements of the
innate immune system in almost all living beings [1]. The
most distinct molecular feature of defensins is their
high pI value, ranging from +6 to +12 as monomers,
manifested by abundant arginine and lysine residues in
their sequences [2]. They kill microorganisms through
permeabilization of the microbial membrane composed
of negatively charged components such as phospholipids,
teichoic acids and lipopolysaccharides [3]. It is believed
that electrostatic interactions dictate not only the uptake
of cationic defensins across the bacterial cell wall but also
their ability to permeabilize the cytoplasmic membrane
and to induce leakage of cellular contents [4].
Many previous studies hypothesized that the major
factor defining the antimicrobial activity of defensin is
its cationicity or its isoelectric point (pI) value, than its
secondary structure [5]. The present study attempted to
verify this hypothesis and generate derivatives of a beta-
defensin with more microbicidal activity by engineering
the protein. Apl_AvBD2 is a b-defensin homologue
identified from domestic duck, and was found to exhibit
antibacterial and immunomodulatory properties [6,7].
In the present study, we made in silico mutants of
Apl_AvBD2 with higher pI values than the wild type, and
analyzed them by Molecular Dynamic (MD) simulation
analysis to find the structure-function relationship.
Subsequently, mutated recombinant proteins were
made in vitro and were evaluated for antibacterial activity
to confirm the observations from the computational
studies. Our results indicated that subtle structural
differences in critical areas of the molecule can drasti-
cally alter the antibacterial potential of b-defensin
molecules.
Methods
Homology modelling of wild type and in silico mutated
Apl_AvBD2 peptides
The predicted amino acid sequence of Apl_AvBD2
[GenBank: AY641439] was subjected to a homology
search using BLAST ([8] and PSI-BLAST [9] against NCBI
PDB database. The top hits were aligned against the
query sequence in a multiple sequence alignment using
Clustal W [10]. We chose the top scoring sequence
Apa_AvBD2 (Spheniscin 2: showed 35% sequence
identity), originating from King Penguin as the template
for further study and the PDB co-ordinate ((PDB id:
1ut3) was retrieved from Protein Data Bank. Homology
modelling was carried out using MODELLER package
[11] based on the sequence alignment generated
between template and target sequences. The atomic
coordinates were obtained from the template structures
to model Apl_AvBD2. Care was taken to make the
coordination geometry of side chain atoms most
favorable. Conformations of a few residues were there-
fore adjusted using loop refinement programme within
MODELLER package. Energy minimization of the top
scored model was carried out with GROMACS 3.3.1 (The
Groningen Machine for Chemical Simulations) [12]
using OPLSAA force field. The minimization was set to
run for 5000 steps or until convergence to machine
precision. PROSA2003 [13] program was used for
validation of the model, by analyzing residue interaction
energy and z-score. These procedures were iterated
several times until a good quality model was obtained.
The dimeric state of Apl_AvBD2 protein was generated
using SymmDock [14], an algorithm for the prediction
of complexes with symmetry by geometry based docking.
The structural representations of Apl_AvBD2 monomers
and dimers were analyzed and visualized using PyMol
software [15]. Based on the structure of a dimeric
complex of Apl_AvBD2 created by the software, the
homology models of the in silico mutants were made.
Less cationic residues in several positions of the wild
type protein were initially mutated to more cationic
arginine residues. However, it was found that many of
them changed the predicted structure of the protein. So
only those mutants, which had the native predicted
structure (Figure 1), were selected for further analysis.
Molecular dynamics (MD) simulation of Apl_AvBD2 and
Its mutant peptides
Molecular dynamics (MD) simulations were performed
using the GROMACS version 3.3.1 and OPLSAA force
field. The initial structures were solvated with three-
point transferable intermolecular potential (TIP3P)
water molecules [16] and appropriate number of
Chloride ions in a rectangular box to neutralize the
system; the box dimensions ensured that any protein
atom was at least 8 Å away from the wall of the box. After
energy minimization, MD simulations were performed
for 100 ps at constant temperature (300 K) and pressure
Figure 1
Predicted amino acid sequences of Apl_AvBD2
and its mutant peptides. The residues mutated by
site-directed mutagenesis are underlined.
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(1 atm) with periodic boundary conditions, particle-
mesh Ewald summation, and a 1-fs time step to heat and
equilibrate the system. This was followed by production
runs of 10 ns duration for each simulation. Structures
were saved every 10 ps for analysis. The relative binding
energies computed using the tool g_energy module of
‘GROMACS 3.3.1, employing molecular mechanics and
a continuum solvent model. The output files (.xvg) from
the GROMACS 3.3.1 was analysed in XMGRACE [17]
software.
The parameters analysed were: area per atom, area per
residue, energy variations (kinetic energy, potential
energy and total energy), van der Waals interactions,
intra-molecular hydrogen bonds, inter-molecular
hydrogen bonds with surrounding water molecules,
radius of gyration, root mean square deviations
(RMSD) of each amino acid residue, root mean square
fluctuations (RMSF) of Ca atoms of each amino acid
residue, solvent accessible surface area, and hydrophobic
and hydrophilic interactions. Pressure, volume, tempera-
ture, minimum distance to periodic image and max-
imum internal distance of the MD simulation system
were examined. The obtained parameters for wild type
and mutant peptides were compared.
In vitro site directed mutagenesis and evaluation of
antibacterial activity of wild type and mutant Apl_AvBD2
Mutagenesis reactions were carried out using the
modified mutagenic primers as per the protocol by
Quick Change Mutagenesis Kit (Stratagene, La Jolla, CA).
Apl_AvBD2-pET-32 gene-vector construct was used for
this purpose. The cloning strategy and recombinant
expression protocols are described elsewhere [6].
Selected clones were sequenced directly using an ABI
3730 Genetic Analyzer automated DNA sequencer (PE
Applied Biosystems, Foster City, CA) for confirmation of
mutation. Recombinant proteins of single amino acid
mutants and serial progressive mutants of Apl_AvBD2,
which were selected for the MD analysis (Figure 1), were
made in vitro. These would make variants of the protein
with pI value ranging from 8.69 to 9.97. These proteins
were expressed in BL21DE3 pLysS bacterial cells, purified
and used for antibacterial assay [6].
Results and discussion
Homology modelling
Apl_AvBD2 was modelled using the known three-
dimensional structure of the Apa_AvBD2 as the template
for homology modelling. Superimposition of the Ca
atoms of the template and target protein gave a
calculated RMSD of 0.39 Å. Analysis of the secondary
structure revealed the presence of mainly two b-strands
in Apl_AvBD2. PROSA2003 Z-scores pointed to the
compatibility between the model and the template. The
Z-scores of both the structures were more or less similar.
PROSA2003 quality check showed that the model of the
Apl_AvBD2 was of good quality, wherein the interaction
energy of each residue with the residual of the protein
was negative. The Apl_AvBD2 model had a Z-score of -
5.55 compared to that of the template (-5.83). Inspec-
tion of PROSA2003 plots revealed no region of the
model with positive PROSA2003 energies (data not
shown).
Molecular dynamics (MD) simulation
In the MD simulation experiments, we selected dimeric
state of the Apl_AvBD2 and its mutants for analysis. This
was because several previous studies have shown that the
Figure 2
Homology models of Apl_AvBD2 and its mutants.
The homology models revealed that the mutated amino acid
residues were projected towards the ‘claw’ region (indicated
by arrow) of the dimer and this may interfere its initial
attachment with the bacterial cell membrane. The dotted
area represents the substituted arginine residues.
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b-defensins function in the form of dimers, which are
their most stable form [2]. We also observed that in MD
simulation analysis using the monomer form of wild
type Apl_AvBD2, the system was not stable after 5 ns,
confirming the monomer’s instability (data not shown).
In the analysis, the dimer models showed a distinct
‘claw’ region formed by the C-terminal tail region of each
monomer (Figure 2). The substituted arginine residues
appeared to be bulkier and projected to the C-terminal
region of the peptides. The steric hindrances due to these
arginine residues were found to be more pronounced in
the mutant peptides. Increase in the number of arginine
residues increased the cationicity of the peptide surface
(Figure 3a). The C-terminal region of wild type peptide
was more flexible compared to the mutants (Figure 3b).
There were variations in the flexibility of different
regions of the dimerized peptides as the number of
arginine residues increased. The Root Mean Square
Deviation (RMSD) and Root Mean Square Fluctuation
(RMSF) were similar in the wild type and mutant type.
A major change observed among the mutants was the
loss of two b-sheets in the dimer complex of I11R
peptide while simulation. The average simulation picture
showed that the secondary structure of wild peptide was
more stable compared to the mutants
The number of hydrogen bonds between the peptide and
the surrounding water molecules were more in mutants
(Figure 4). As arginine residues increased, there was
Figure 3
Distribution of charged residues and flexibility of Apl_AvBD2 and its mutants during MD simulations. (a)
Distribution of charged residues on the solvent-accessible surfaces. Positively charged residues are represented as blue and
negatively charged areas shown as red. (The potentials range from -5 kT/e for red to +5 kT/e for blue). As the number of
arginine residues increased the cationicity of the peptide surface also increased. (b) Flexible regions in the average MD
simulation structure of the peptides. The C-terminal residues and the loops of wild type, F7R, I11R and F7R I11R V24R S38R
appeared to be more flexible. The dark blue areas represent the rigid regions and flexibility of the structure increases as dark
blue turns light blue to red. The length of the b-sheets was varied in some of the mutants. The single amino acid mutant of
Apl_AvBD2 (I11R) showed loss of two b-sheets in its structure.
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reduction in hydrophobicity and increase in solvent
accessible surface area. This change was visible with the
substitution of a single amino acid itself (Figure 5). It is
reported that antimicrobial peptides need an optimal
“hydrophobicity threshold” for insertion into zwitter-
ionic micellar membranes [18] and hydrophobic
interactions are necessary for the membrane ‘sinking’
process after the initial attachment [19]. Ideally, active
antimicrobial peptides must have an appropriate balance
of hydrophobicity and net positive charge [20]. The
mutations introduced to the wild type Apl_AvBD2 were
found to disturb this balance.
Figure 4
Hydrogen bonds of Apl_AvBD2 and its mutants with water molecules. (a) Hydrogen bond pairs within 0.35 nm and
(b) Hydrogen bond pairs > 0.35 nm. The graph indicates average of values obtained during the entire period of simulation for
each mutant. The representative original graphical data obtained for wild type, single mutant and progressive serial mutant
are shown as (c), (d) & (e). As cationicity increases, the number of hydrogen bonds between peptide and the surrounding
water molecules also increases. The change was visible with the substitution of a single amino acid itself.
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Suresh and Verma [2] suggested the importance of the
C-terminal ‘claw’ in the antibacterial activity of b-defensins.
This region is supposed to act as a prehensile grasp to the
bacterial cell membrane during the initial interaction.
The shape and the orientation of C-terminal ‘claw’ region
in the Apl_AvBD2 dimers were varied as time progresses
(Figure 6). This structure was well formed and intact
during the entire simulation period in the wild type
Figure 5
Average hydrophilicity, hydrophobicity and solvent accessible surface area of Apl_AvBD2 and its mutants.
(A) Average Hydrophilicity, (B) Average hydrophobicity. The graph represents average of the values obtained during the entire
period of simulation for each mutant. The representative original data obtained for wild type (C1) and one of the mutants (C2)
are shown. (D) Solvent accessible surface area-merged figure of the data obtained for individual mutants. Original data for one
of the mutants is also shown (E).
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Figure 6
Conformations Apl_AvBD2 and its mutants during the MD simulation experiments for 1000 ps. The initial and
final conformations are shown. Apl_AvBD2 form a stable dimer in the simulation system. The amino acids in the wild peptide
are shown as sticks in different colours. The positions of amino acids in the mature peptide region selected for arginine
substitution are represented as follows; red: 7th position (Phenylalanine to Arginine), yellow: 11th position (Isoleucine to
Arginine), Magenta: 24th position (Valine to Arginine), Orange: 38th position (Serine to Arginine). The C-terminal residues
form a distinct ‘claw region (indicated by arrows) of the wild type Apl_AvBD2. In all the mutants, the shape and orientation of
this claw region became less distinct during simulation.
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peptide compared to the mutant types. This observation
predicted an altered activity of the mutant peptides during
functional assays.
Functional evaluation of the antibacterial activity of wild
type and mutant Apl_AvBD2
The recombinant wild type Apl_AvBD2 protein showed
antibacterial activity against the Gram negative organism
E. coli NCIM2685 and against the Gram positive
Staphylococcus aureus NCIM2654 (Figure 7) in the
standard plate count assay (CFU/mL). The protein
brought about three-log reduction in the colony forming
units (cfu) of these test microbes as evidenced by the
assay. However, the mutant peptides exhibited complete
loss of antimicrobial activity. The serial mutants and
single amino acid mutants showed this loss of activity.
This corroborated observations in our preliminary MD
simulation analysis, wherein the mutants, which had an
intact predicted secondary structure, showed differences
during the dynamic state of simulation. This further
confirms the previous observations [21] that though the
primary structure is the most important determinant of
the activity of an antimicrobial peptide, the number of
hydrogen bonds, hydrophobicity, water solubility, elec-
trostatic interactions, potential for oligomerization and
secondary structures such as a-helix and b-sheets also
play critical roles in its bactericidal activity.
Conclusion
From the results obtained in this study, it can be
concluded that the increase in cationicity alone may
not enhance the antibacterial activity of defensins. The
antimicrobial activity of these peptides requires a
balance between its cationicity and hydrophobicity.
Figure 7
Evaluation of antibacterial activity of wild type and mutant type Apl_AvBD2. (a) SDS-PAGE of purified recombinant
proteins (indicated by arrows). The recombinant wild Apl_AvBD2 showed antibacterial activity against the (b) Gram negative
bacteria E. coli (NCIM 2685) and (c) Gram positive bacteria Staphylococcus aureus (NCIM 2654) in the standard plate count
assay (SPC). The numbers in graphs represent: (1) wild type (2) F7R (3) I11R (4) V24R (5) F7R I11R (6) F7R I11R V24R (7) F7R
I11R V24R S38R. Mutant proteins do not show antibacterial activity.
BMC Bioinformatics 2010, 11(Suppl 1):S7 http://www.biomedcentral.com/1471-2105/11/S1/S7
Page 8 of 9
(page number not for citation purposes)
The substitution of hydrophobic residues with more
cationic hydrophilic residues leads to complete loss of
activity. Moreover, even a single amino acid change can
cause deleterious effect in the antibacterial activity. Most
of the naturally occurring antimicrobial peptides have
undergone evolutionary selection to perform best in the
host. Manipulations to enhance its effects may not
always yield viable results and has to be done prudently.
MD simulation experiments would be useful while
manipulating antimicrobial peptides to improve its
activity by mutagenesis or by chemical synthesis.
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